In addition, we found that low‐ and medium‐dose formoterol treatment alleviated apoptosis of VSMCs in the aortic tissues induced by EPO, suggesting anti‐apoptosis is another important therapeutic mechanism of formoterol in EPO‐induced AAA. The gene discussed is EPO; the disease is triple-A syndrome.